Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ITCH × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 120 Lymphoma 90 Lymphoma, Large B-Cell, Diffuse 79 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Burkitt Lymphoma 31 Multiple Myeloma 26 Lymphoma, Non-Hodgkin 26 Lymphoma, Follicular 26 Leukemia 26 Hodgkin Disease 24 Lymphoma, Mantle-Cell 18 Neoplasms 16 Lymphoma, T-Cell, Peripheral 16 Lymphoma, B-Cell 14 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, Large-Cell, Anaplastic 11 Dendritic Cell Sarcoma, Interdigitating 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Recurrence 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Neoplasms, Plasma Cell 7 Neoplasm Metastasis 7 Waldenstrom Macroglobulinemia 6 Primary Myelofibrosis 6 Lymphoma, T-Cell 6 Immunoblastic Lymphadenopathy 6 HIV Infections 5 Graft vs Host Disease 5 Blast Crisis 5

Interventions

fexofenadine 1 Prednisone 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01683552 2012-09-12

AprepIt

Campus Bio-Medico University

Phase 2 Completed

ITCH

Data powered by HemOnc (CC BY 4.0) Colophon ⚡